190 related articles for article (PubMed ID: 37774369)
1. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
Ivy ZK; Belcher JD; Khasabova IA; Chen C; Juliette JP; Abdulla F; Ruan C; Allen K; Nguyen J; Rogness VM; Beckman JD; Khasabov SG; Gupta K; Taylor RP; Simone DA; Vercellotti GM
Blood; 2023 Nov; 142(22):1918-1927. PubMed ID: 37774369
[TBL] [Abstract][Full Text] [Related]
2. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
3. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.
Uhelski ML; Gupta K; Simone DA
Pain; 2017 Sep; 158(9):1711-1722. PubMed ID: 28570479
[TBL] [Abstract][Full Text] [Related]
5. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
6. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of nociceptors by prostaglandin E
Khasabova IA; Uhelski M; Khasabov SG; Gupta K; Seybold VS; Simone DA
Blood; 2019 May; 133(18):1989-1998. PubMed ID: 30796025
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease.
Khasabova IA; Gable J; Johns M; Khasabov SG; Kalyuzhny AE; Golovko MY; Golovko SA; Kiven S; Gupta K; Seybold VS; Simone DA
Haematologica; 2023 Mar; 108(3):859-869. PubMed ID: 35615929
[TBL] [Abstract][Full Text] [Related]
9. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.
Cain DM; Vang D; Simone DA; Hebbel RP; Gupta K
Br J Haematol; 2012 Feb; 156(4):535-44. PubMed ID: 22171826
[TBL] [Abstract][Full Text] [Related]
10. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
Front Immunol; 2020; 11():613278. PubMed ID: 33542720
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors.
Garrison SR; Kramer AA; Gerges NZ; Hillery CA; Stucky CL
Mol Pain; 2012 Sep; 8():62. PubMed ID: 22963123
[TBL] [Abstract][Full Text] [Related]
12. Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease.
Duru AN; Ocheni S; Ibegbulam O; Okpala I
Front Genome Ed; 2021; 3():722190. PubMed ID: 34713264
[No Abstract] [Full Text] [Related]
13. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
[TBL] [Abstract][Full Text] [Related]
14. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
15. Functional MRI BOLD response in sickle mice with hyperalgesia.
Wang Y; Wang X; Chen W; Gupta K; Zhu XH
Blood Cells Mol Dis; 2017 Jun; 65():81-85. PubMed ID: 28579187
[TBL] [Abstract][Full Text] [Related]
16. Significant Quantitative Differences in Orexin Neuronal Activation After Pain Assessments in an Animal Model of Sickle Cell Disease.
Richardson K; Sweatt N; Tran H; Apprey V; Uthayathas S; Taylor R; Gupta K
Front Mol Biosci; 2020; 7():5. PubMed ID: 32118032
[TBL] [Abstract][Full Text] [Related]
17. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease.
Shi H; Shao B; Gao L; Venkatesan T; McDaniel JM; Zhou M; McGee S; Yu P; Ahamed J; Journeycake J; George JN; Xia L
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207592119. PubMed ID: 35969769
[TBL] [Abstract][Full Text] [Related]
18. Children and adolescents with sickle cell disease have worse cold and mechanical hypersensitivity during acute painful events.
Brandow AM; Hansen K; Nugent M; Pan A; Panepinto JA; Stucky CL
Pain; 2019 Feb; 160(2):407-416. PubMed ID: 30247266
[TBL] [Abstract][Full Text] [Related]
19. Exacerbated metabolic changes in skeletal muscle of sickle cell mice submitted to an acute ischemia-reperfusion paradigm.
Chatel B; Messonnier LA; Vilmen C; Bernard M; Pialoux V; Bendahan D
Clin Sci (Lond); 2018 Oct; 132(19):2103-2115. PubMed ID: 30185507
[TBL] [Abstract][Full Text] [Related]
20. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
